Akebia Therapeutics, Inc. - Demonstração de Resultados (TTM)

Akebia Therapeutics, Inc.
US ˙ NasdaqCM ˙ US00972D1054

Demonstração de Resultados (TTM)

A Demonstração de Resultados de Akebia Therapeutics, Inc. mostra mudanças na receita e despesas ao longo de um período de tempo. Os dados da Demonstração de Resultados incluem Vendas e Receita, Lucro Bruto, Pesquisa e Desenvolvimento (P&D), Despesas de Vendas, Gerais e Administrativas (SG&A), Renda Operacional, Despesa com Imposto de Renda, Despesa com Juros, Renda Não Operacional, Lucro por Ação (EPS) e Ações em Circulação.

Todos os números são vezes 1,000,000 exceto unidades por ação.

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
Receita 222 211 212 221 294 294 292 271 201 194 195 187 174 170 160 185 204 225 236 232
Mudar (%) -5.06 0.46 4.40 33.24 -0.01 -0.64 -7.39 -25.84 -3.32 0.21 -3.80 -6.80 -2.65 -5.71 15.44 10.18 10.47 4.94 -1.61
% da receita 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Custo das vendas 246 232 229 252 207 223 22 -15 9 -11 40 31 30 27 26 32 34 38 40 42
Mudar (%) -5.58 -1.34 9.72 -17.92 8.18 -89.93 -165.35 -162.52 -219.23 -462.85 -21.87 -4.09 -9.55 -2.99 20.84 8.20 9.83 7.48 4.01
% da receita 110.95 110.35 108.36 113.88 70.16 75.91 7.69 -5.43 4.58 -5.64 20.43 16.59 17.08 15.87 16.32 17.09 16.78 16.68 17.08 18.06
Lucro Operacional Bruto -24 -22 -18 -31 88 71 270 286 192 205 155 156 145 143 134 153 170 188 196 190
Mudar (%) -10.29 -18.81 73.36 -386.40 -19.28 280.67 5.77 -32.88 7.03 -24.52 0.84 -7.34 -1.23 -6.22 14.39 10.59 10.60 4.44 -2.76
% da receita -10.95 -10.35 -8.36 -13.88 29.84 24.09 92.31 105.43 95.42 105.64 79.57 83.41 82.92 84.13 83.68 82.91 83.22 83.32 82.92 81.94
Vendas, Gerais e Administrativas 163 170 174 177 168 153 139 119 114 105 100 101 100 104 107 107 106 109 107 112
Mudar (%) 3.78 2.65 1.86 -5.31 -8.61 -9.70 -14.08 -4.37 -8.06 -4.27 0.38 -0.12 3.79 2.15 0.29 -0.34 2.42 -1.45 4.37
% da receita 73.66 80.53 82.28 80.27 57.05 52.14 47.39 43.97 56.69 53.91 51.50 53.74 57.59 61.40 66.52 57.78 52.27 48.46 45.50 48.27
P&D 130 131 100 85 63 53 41 36 38 38 41 47 62 67
Mudar (%) 0.51 -23.46 -14.70 -26.06 -15.78 -23.62 -11.94 5.38 0.06 8.93 15.73 31.29 8.10
% da receita 44.44 48.24 49.79 43.93 32.41 28.37 23.25 21.03 23.51 20.37 20.14 21.10 26.40 29.01
OpEx 441 436 440 465 411 413 327 271 259 215 239 221 207 203 206 203 200 203 210 222
Mudar (%) -1.05 0.73 5.81 -11.72 0.59 -20.79 -17.13 -4.41 -16.99 11.17 -7.64 -6.31 -1.88 1.65 -1.57 -1.68 1.69 3.48 5.41
% da receita 198.73 207.13 207.67 210.47 139.45 140.29 111.84 100.08 129.00 110.76 122.86 117.96 118.58 119.52 128.85 109.86 98.04 90.25 88.99 95.33
Lucro operacional -219 -226 -228 -244 -116 -119 -35 -0 -58 -21 -44 -34 -32 -33 -46 -18 4 22 26 11
Mudar (%) 3.01 0.97 7.12 -52.42 2.12 -70.80 -99.37 26,595.78 -64.14 112.98 -24.43 -3.60 2.28 39.37 -60.52 -121.92 448.96 18.45 -58.29
% da receita -98.73 -107.13 -107.67 -110.47 -39.45 -40.29 -11.84 -0.08 -29.00 -10.76 -22.86 -17.96 -18.58 -19.52 -28.85 -9.86 1.96 9.75 11.01 4.67
Despesa com juros -14 -17 -20 -20 -20 -19 -16 -12 -9 -6 -6 -7 -7 -13 -18 -23 -28 -26 -24 -21
Mudar (%) 19.51 16.26 1.28 0.36 -5.57 -18.36 -22.32 -27.85 -28.91 -3.49 15.53 7.26 70.25 42.90 28.99 19.97 -6.80 -7.82 -12.73
% da receita -6.49 -8.17 -9.46 -9.18 -6.91 -6.53 -5.36 -4.50 -4.38 -3.22 -3.10 -3.72 -4.28 -7.49 -11.35 -12.69 -13.81 -11.65 -10.24 -9.08
Resultado líquido -300 -299 -282 -276 -163 -158 -94 -58 -98 -59 -52 -43 -40 -46 -69 -45 -36 -16 -5 -21
Mudar (%) -0.14 -5.73 -2.15 -40.76 -3.33 -40.37 -38.88 70.53 -40.33 -11.41 -17.12 -6.02 13.72 50.92 -34.72 -19.48 -56.41 -66.39 283.74
% da receita -135.00 -142.00 -133.25 -124.88 -55.52 -53.68 -32.22 -21.26 -48.89 -30.18 -26.68 -22.99 -23.18 -27.07 -43.33 -24.51 -17.91 -7.07 -2.26 -8.83

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:AX9 € 0,81
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista